Tighter watch urged on adenoviral vectors…

Paul Smaglik

Nature, 1999, vol. 402, issue 6763, 707-707

Abstract: [WASHINGON] Gene therapy researchers using adenoviral vectors should apply stricter quality controls and more precise monitoring because of the ‘narrow window’ that separates their potential efficacy from toxicity, says a National Institutes of Health advisory panel.

Date: 1999
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/45321 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:402:y:1999:i:6763:d:10.1038_45321

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/45321

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().